Beijing, June 22, 2025 (Xinhua) – Yu Wenming, former head of the National Administration of Traditional Chinese Medicine (NATCM), is under investigation for suspected severe violations of duty, according to an official announcement made today. The investigation is being conducted by the National Supervisory Commission.
The brief statement, released by Chinese authorities, marks the latest development in the ongoing anti-corruption campaign within the country’s healthcare sector. The news has reverberated across both the traditional medicine community and the broader public, raising questions about the scope and potential impact of the investigation.
Yu Wenming, born in June 1963 in Shanxian, Shandong Province, joined the workforce in August 1988. A member of the Chinese Peasants’ and Workers’ Democratic Party, one of China’s eight legally recognized non-Communist parties, Yu’s career has been deeply intertwined with the development of traditional Chinese medicine (TCM). Prior to his leadership role at NATCM, he served as the deputy director of the Traditional Chinese Medicine and Liaison Department at the China Traditional Chinese Medicine News Agency.
The investigation into Yu Wenming comes at a time when TCM is playing an increasingly prominent role in China’s healthcare system, both domestically and internationally. The Chinese government has been actively promoting TCM as a vital part of its healthcare strategy, emphasizing its unique approach to disease prevention and treatment.
While details of the specific allegations against Yu Wenming remain scarce, the phrase severe violations of duty typically points to potential abuse of power, corruption, or other forms of misconduct related to his official position.
The National Supervisory Commission, established in 2018, is a powerful anti-graft agency with the authority to investigate and prosecute government officials suspected of corruption and other malfeasance. Its involvement underscores the seriousness with which the authorities are treating the case.
The outcome of the investigation into Yu Wenming is likely to have significant implications for the future of TCM in China. It could lead to increased scrutiny of the sector and potentially trigger reforms aimed at strengthening oversight and preventing corruption.
The investigation is ongoing, and further details are expected to be released as the process unfolds.
References:
- Zhongxin News Agency. (2025, June 22). 中国国家中医药管理局原局长于文明被查 [Former Head of China’s National Administration of Traditional Chinese Medicine Under Investigation]. Retrieved from [Insert URL here if available]
Views: 0